Printer Friendly

Potential new vaccine target for bacterial meningitis identified.

Washington, May 25 ( ANI ): Researchers have identified a protein responsible for bacterial meningitis.

Bacterial meningitis is an infection of the meninges, the protective membrane that covers the spinal cord and brain.

Children, elderly patients and immunocompromised patients are at a higher risk for the development of severe bacterial meningitis.

Recently, a team of researchers at the University of Adelaide in Australia sought to identify new vaccine targets in Streptococcus pneumoniae, which is the most common cause of bacterial meningitis in the world.

Led by Dr. Abiodun Ogunniyi, the research team developed a new method of screening for bacterial genes that are expressed during meningitis in brain tissue.

Using a mouse model system, the researchers examined mice infected with two different strains of S. pneumoniae.

They identified a protein known as glycerophosphate oxidase, and showed that this protein was critical for the progression of bacteria from blood to brain in mice.

They went on to show that a vaccine against glycerophosphate oxidase protected mice from invasive pneumococcal disease.

Their results not only suggest a new strategy for immunizing against Streptococcus pneumoniae, but also provide a blueprint for discovering additional genes from other pathogens that contribute to meningitis. ( ANI )

]]>

Copyright 2012 aninews.in All rights reserved.

Provided by Syndigate.info an Albawaba.com company
COPYRIGHT 2012 Al Bawaba (Middle East) Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Asian News International
Date:May 25, 2012
Words:212
Previous Article:Asteroid measured when nudged by sunlight.
Next Article:'Blade Runner' voted best sci-fi fantasy and horror film.
Topics:

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |